Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$242K Sell
1,653
-6,095
-79% -$917K 0.09% 122
2016
Q3
$1.29M Buy
7,748
+65
+0.8% +$11K 0.48% 60
2016
Q2
$1.17M Sell
7,683
-3,250
-30% -$505K 0.47% 62
2016
Q1
$1.64M Buy
10,933
+1,608
+17% +$239K 0.66% 51
2015
Q4
$1.51M Buy
+9,325
New +$1.47M 0.6% 51

Other funds holding AMGN

CG Asset Management's AMGN Position: Q4 2016 in Review

CG Asset Management reduced its Amgen (AMGN) stake by 79% in Q4 2016, selling an estimated $917K and leaving 1,653 shares worth $242K. The position accounts for 0.09% of the portfolio, ranked #122.

CG Asset Management first reported a position in AMGN in Q4 2015 and has held it in 5 quarters since. The position peaked at $1.64M in Q1 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • CG Asset Management held 1,653 shares of Amgen worth $242K as of Q4 2016.
  • CG Asset Management sold 6,095 Amgen shares in Q4 2016, an estimated $917K.
  • Amgen made up 0.09% of CG Asset Management's portfolio in Q4 2016, its #122 holding.
  • CG Asset Management first reported a position in Amgen in Q4 2015 and has held it in 5 quarters since.
  • CG Asset Management's Amgen position peaked at $1.64M in Q1 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.